DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice

Infection and Immunity

Volumn 68, Issue 1, 2000, Pages 38-45

  Vercammen, M ^a   Scorza, T ^a   Huygen, K ^a   De Braekeleer, J ^a   Diet, R ^a   Jacobs, D ^b   Saman, E ^b   Verschueren, H ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b INNOGENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CYST; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PARASITE IMMUNITY; PLASMID; PRIORITY JOURNAL; PROTOZOAL INFECTION; SEROCONVERSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII; VACCINATION;

EID: 0033961350     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.1.38-45.2000     Document Type: Article

References (49)

1. Alexander, J., H. Jebbari, H. Bluethmann, A. Satoskar, and C. W. Roberts. 1996. Immunological control of Toxoplasma gondii and appropriate vaccine design. Curr. Top. Microbiol. Immunol. 219:188-190.
2. Angus, C. W., D. Klivington, J. Wyman, and J. A. Kovacs. 1996 Nucleic acid vaccination against Toxoplasma gondii in mice. J. Eukaryot. Microbiol. 43: 117S.
3. Araujo, F. G., D. M. Williams, F. C. Grumet, and J. Remington. 1976. Strain-dependent differences in murine susceptibility to Toxoplasma. Infect. Immun. 13:1528-1530.
4. Bachmann, B. J. 1987. Derivations and genotypes of some mutant derivations of Escherichia coli K-12, p. 1190-1219. In F. C. Neidhardt, J. L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium: cellular and molecular biology. American Society for Microbiology, Washington, D.C.
5. Blackwell, J. M., C. W. Roberts, and J. Alexander. 1993. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol. 15:317-324.
6. Brown, C. R., and R. McLeod. 1990. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145: 3438-3441.
7. Brown, C. R., C. A. Hunter, R. G. Estes, E. Beckmann, J. Forman, C. David, J. S. Remington, and R. McLeod. 1995. Definitive identification of a gene that confers resistance against toxoplasmosis. Immunology 85:419-428.
8. Cesbron-Delauw, M. F., B. Guy, G. Torpier, R. J. Pierce, G. Lenzen, J. Y. Cesbron, H. Charif, P. Lepage, F. Darcy, J. P. Lecocq, and A. Capron. 1989. Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gundii. Proc. Natl. Acad. Sci. USA 86:7537-7541.
9. Chardès, T., I. Bourguin, M.-N. Mevelec, J.-F. Dubremetz, and D. Bout. 1990. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect. Immun. 58:1240-1246.
10. Denkers, E. Y., and R. T. Gazzinelli. 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569-588.
11. Donnelly, J. J., J. B. Ulmer, and M. A. Liu. 1994. Immunization with DNA. J. Immunol. Methods 176:145-152.
12. + cell-, Interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 183:1739-1746.
13. Dupre, L., O. Poulain-Godefroy, E. Ban, N. Ivanoff, M. Mekranfar, A. M. Schacht, A. Capron, and G. Riveau. 1997. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansomi 28 kDa glutathione S-transferase. Parasite Immunol. 19:505-513.
14. Duquesne, V., C. Auriault, H. Gras-Masse, C. Boutillon, F. Darcy, M.-F. Cesbron-Delauw, A. Tartar, and A. Capron. 1991. Identification of T cell epitopes within a 23-kD antigen (p24) of Toxoplasma gondii. Clin. Exp. Immunol. 84:527-534.
15. Fischer, H.-G., S. Stachelhaus, M. Sahm, H. E. Meyer, and G. Reichmann. 1998. GRA7, an excretory 29 kDa Tamplasma gondii dense granule antigen released by infected host cells. Mol. Biochem. Parasitol. 91:251-262.
16. Gardner, M. J., D. L. Doolan, R. C. Hedstrom, R. Wang, M. Sedegah, R. A. Gramzinski, J. C. Aguiar, H. Wang, M. Margalith, P. Hobart, and S. L. Hoffman. 1996. DNA vaccines against malaria: immunogenicity and protection in a rodent model. J. Pharm. Sci. 85:1294-300.
17. Homan, W., M. Vercammen, J. De Braekeleer, and H. Verschueren. Identification of a 200- to 300-fold repetitive 529-bp DNA fragment in Toxoplasma gondii and its possible use for diagnostic and quantitative PCR. Int. J. Parasitol., in press.
18. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. Randall Deck, C. M. De Witt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J.-P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
19. Huygen, K. 1998. DNA vaccines: application to tuberculosis. Int. J. Tuberc. Lung Dis. 2:1-8.
20. Jacobs, D., J.-F. Dubremetz, A. Loyens, F. Bosman, and E. Saman. 1998. Identification and heterologous expression of a new dense granule protein (GRA7) from Toxoplasma gondii. Mol. Biochem. Parasitol. 91:237-249.
21. Jacobs, D., M. Vercammen, and E. Saman. 1999. Evaluation of recomhinant dense granule antigen 7 (GRA7) of Toxoplasma gandii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin. Diagn. Lab. Immunol. 6:24-29.
22. Jenkins, M., D. Kerr, R. Fayer, and R. Wall. 1995. Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen. Vaccine 13:1658-1664.
23. Kasper, L. H., and D. Buzoni-Gatel. 1998. Some opportunistic parasitic infections in AIDS: candidiasis, pneumocystosis, cryptosporidiosis, toxoplasmosis. Parasitol. Today 14:150-156.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
25. Laugier, M., and M. Quillici. 1970. Intérêt expérimental d'une souche de toxoplasmose peu pathogène pour la souris. Ann. Parasitol. Hum. Comp. 45:389-403.
26. Le Gros, G., S. W. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro; IL-2 and IL-4 are required for in vitro generation of IL-4 producing cell. J. Exp. Med. 172:921-929.
27. Liesenfeld, O., J. Kosek, J. S. Remington, and Y. Suzuki. 1996. Association of CD4+ T-cell dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184:597-607.
28. Luke, C. J., K. Carmer, X. Liang, and A. G. Barbour. 1997. An OspA-hased DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 175:91-97.
29. McCluskie, M. J., M. C. L. Brazolot, R. A. Gramzinski, H. L. Robinson, J. C. Santoro, J. T. Fuller, G. Widera, J. R. Haynes, R. H. Purcell, and H. L. Davis. 1999. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol. Med. 5:287-300.
30. McLeod, R., P. Eisenhauer, D. Mack, C. Brown, G. Filice, and G. Spitainy. 1989. Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 142:3247-3255.
31. Mor, G., D. M. Klinman, S. Shapiro, E. Hagiwara, M. Sedegah, J. A. Norman, S. L. Hoffman, and A. D. Steinberg. 1995. Complexity of the cytokine and antibody response elicited by immunising mice with Plasmodium yoelii circumsporozite protein plasmid DNA. J. Immunol. 155:2039-2046.
32. Nara, T., K. Tanabe, Y. Mahakunkijcharoen, Y. Osada, N. Matsumoto, K. Kita, and S. Kojima. 1997. The B cell epitope of paramyosin recognised by a partially protective monoclonal IgE antibody to Schistosoma japonicum. Vaccine 15:79-84.
33. Oliveira, S. C., G. M. Rosinha, C. F. de-Brito, C. T. Fonseca, R. R. Afonso, M. C. Costa, A. M. Goes, E. L. Rech, and V. Azevedo. 1999. Immunological properties of gene vaccines delivered by different routes. Braz. J. Med. Biol. Res. 32:207-214.
34. Quelle, F. W., K. Shimoda, W. Thierfelder, C. Fisher, A. Kimm, S. M. Ruben, J. L. Cleveland, J. H. Pierce, A. D. Keegan, and K. Nelms. 1995. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in response to IL-4 and IL-3 hut not required for mitogenesis. Mol. Cell. Biol. 15:3336-3343.
35. Saavedra, R., F. De Meuter, and P. Hérion. 1990. Monoclonal antibodies identify new Toxoplasma gondii soluble antigens. Hybridoma 9:453-463.
36. Saavedra, R., F. De Meuter, J.-L. Decourt, and P. Hérion. 1991. Human T cell clone identifies a potentially partially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli. J. Immunol. 147:1975-1982.
37. Saavedra, R., M. A. Becerill, C. Dubeaux, R. Lippens, M.-J. De Vos, P. Hérion, and A. Bollen. 1996. Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infect. Immun. 64:3858-3862.
38. Sadak, A. Z., B. Taghy, B. Fortier, and J.-F. Dubremetz. 1988. Characterization of a family of rhoptry proteins of Toxoplasma gondii. Mol. Biochem. Parasitol. 29:203-211.
39. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
40. Smooker, P. M., K. R. Steeper, D. R. Drew, R. A. Strugnell, and T. W. Spithill. 1999. Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression. Parasite Immunol. 21:357-364.
41. Supply, P., P. Sutton, S. N. Coughlan, K. Bilo, E. Saman, A. J. Trees, M. L. Cesbron-Delauw, and C. Locht. 1999. Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii. Vaccine 17:705-714.
42. Suzuki, Y., K. Joh, M. A. Orellana, F. K. Conley, and J. S. Remington. 1991. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732-739.
43. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806.
44. Tighe, H., M. Corr, M. Roman, and E. Raz. 1998. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today 19:89-97.
45. Van Gelder, F., F. Bosman, F. De Meuter, H. Van Heuverswyn, and P. Hérion. 1993. Scrodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli. J. Clin. Microbiol. 31:9-15.
46. Vercammen, M., M.-L. Dardé, A. El Bouhdidi, A. Ben Messaoud, F. De Meuter, J.-F. Dubremetz, and Y. Carlier. 1998. Fc receptor activity of Toxoplasma gondii tachyzoites: immunoglobulin binding by T, gondii strains with different isoenzyme patterns, and by SAG1 and SAG2 deficient mutants, p. 1027-1032. In Proceedings of the ICOPA IX, 9th International Congress of Parasitology, Monduzzi Editore, Bologna, Italy.
47. Xu, D., and F. Y. Liew. 1994. Genetic vaccination against leishmaniasis. Vaccine 12:1534-1536.
48. Xu, D., and F. Y. Liew. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84:173-176.
49. Yang, W., G. J. Waine, and D. P. McManus. 1995. Antibodies to Schistosoma japonicum (Asian bloodfluke) paramyosin induced by nucleic acid vaccination. Biochem. Biophys. Res. Commun. 212:1029-1039.